Abstract
Although surgical resection is directly related with anatomic boundaries and as a summary an all-or-none modality, even surgical prognosticators to define post-resection functional status could remain suboptimal. Radiotherapy, on the other site, is not an anatomical dissection, not a straightforward modality, and cannot be easily defined in numbers because of lack of correlation of effected anatomic units and heterogeneity of the effect on each unit. So evaluation before radiotherapy is overall a risk assessment with the baseline functional status and radiotherapy-induced expected loss in the function. Radiotherapy-triggered changes are gradual over time, sometimes as unusual reactions or hypersensitivity pneumonitis, and the compensation by the unirradiated lung is unpredictable. Overall, a radiation oncologist is expected to minimize the potential toxicity risks in an environment of various combinations of medical inoperability, poor pulmonary functionality, riskily localized or large parenchyma endangering bulky tumors, etc. and is mostly asked to be prepared to accept potential morbidities in this referred population with great expectations who will face a certain death if not treated.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Woel RT, Munley MT, Hollis D, Fan M, Bentel G, Anscher MS, et al. The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys. 2002;52(1):58–67. PubMed Epub 2002/01/05. eng.
Seppenwoolde Y, Muller SH, Theuws JC, Baas P, Belderbos JS, Boersma LJ, et al. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000;47(3):681–90. PubMed Epub 2000/06/06. eng.
Zhang J, Ma J, Zhou S, Hubbs JL, Wong TZ, Folz RJ, et al. Radiation-induced reductions in regional lung perfusion: 0.1–12 year data from a prospective clinical study. Int J Radiat Oncol Biol Phys. 2010;76(2):425–32. PubMed Epub 2009/07/28. eng.
Farr KP, Kallehauge JF, Møller DS, Khalil AA, Kramer S, Bluhme H, et al. Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study. Radiother Oncol. 2015;117(1):9–16. Epub 2015/08/21.eng
Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 2009;34(1):17–41. PubMed Epub 2009/07/02. eng.
Ueki N, Matsuo Y, Togashi Y, Kubo T, Shibuya K, Iizuka Y, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2015;10(1):116–25. PubMed Epub 2014/11/08. eng.
Nagano T, Kotani Y, Fujii O, Demizu Y, Niwa Y, Ohno Y, et al. A case of acute exacerbation of idiopathic pulmonary fibrosis after proton beam therapy for non-small cell lung cancer. Jpn J Clin Oncol. 2012;42(10):965–9. PubMed Epub 2012/07/25. eng.
Protocol N-B. A Phase 1 study of stereotactic body radiotherapy (SBRT) for the treatment of multiple metastases. Available from: https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1311.
Protocol R. A Randomized phase II study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. 2015. Available from: https://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0915.
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(17):2758–65. PubMed Epub 2009/05/01. eng.
Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132(1):193–9. PubMed Epub 2007/05/17. eng.
Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(35):5153–9. PubMed Epub 2010/11/03. eng.
Kim H, Lussier YA, Noh OK, Li H, Oh YT, Heo J. Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2014;113(3):374–8. PubMed Epub 2014/12/03. eng.
Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S70–6. PubMed Pubmed Central PMCID: 3576042, Epub 2010/03/05. eng.
Kabolizadeh P, Kalash R, Huq MS, Greenberger JS, Heron DE, Beriwal S. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis. Am J Clin Oncol. 2015;38(4):401–4. PubMed Epub 2013/09/26. eng.
Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 2000;48(1):89–94. PubMed Epub 2000/08/05. eng.
Wang J, Cao J, Yuan S, Ji W, Arenberg D, Dai J, et al. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys. 2013;85(3):798–804. PubMed Pubmed Central PMCID: 3646086, Epub 2012/07/28. eng.
Enache I, Noel G, Jeung MY, Meyer N, Oswald-Mammosser M, Pistea C, et al. Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: a prospective study. Respiration. 2013;86(2):100–8. PubMed Epub 2012/11/17. eng.
Takeda A, Ohashi T, Kunieda E, Sanuki N, Enomoto T, Takeda T, et al. Comparison of clinical, tumour-related and dosimetric factors in grade 0–1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours. Br J Radiol. 2012;85(1013):636–42. PubMed Pubmed Central PMCID: 3479872, Epub 2012/01/19. eng.
Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012;82(3):1149–56. PubMed Epub 2011/06/07. eng.
Stephans KL, Djemil T, Reddy CA, Gajdos SM, Kolar M, Machuzak M, et al. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2009;4(7):838–44. PubMed Epub 2009/06/03. eng.
Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol. 2014;53(5):605–12. PubMed Epub 2013/08/21. eng.
Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012;51(8):975–83. PubMed Pubmed Central PMCID: 3557496, Epub 2012/09/07. eng.
Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2009;91(3):427–32. PubMed Epub 2008/10/22. eng.
Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose. Int J Radiat Oncol Biol Phys. 2013;85(2):522–7. PubMed Epub 2012/05/15. eng.
Huang Q, Xie F, Ouyang X. Predictive SNPs for radiation-induced damage in lung cancer patients with radiotherapy: a potential strategy to individualize treatment. Int J Biol Markers. 2015;30(1):e1–11. PubMed Epub 2014/09/30. eng.
Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(1):94–102. PubMed Epub 2007/02/27. eng.
Khalil AA, Hoffmann L, Moeller DS, Farr KP, Knap MM. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy. Acta Oncol. 2015;54(9):1343–9. PubMed Epub 2015/07/23. eng.
Chen J, Hong J, Zou X, Lv W, Guo F, Hong H, et al. Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis. J Radiat Res. 2015;56(6):883–8. Epub 2015/10/09.eng.
Lopez Guerra JL, Gomez DR, Zhuang Y, Levy LB, Eapen G, Liu H, et al. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(4):e537–43. PubMed Pubmed Central PMCID: 3923580, Epub 2012/03/17. eng.
Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, et al. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(5):1573–9. PubMed Pubmed Central PMCID: 3931002, Epub 2012/07/10. eng.
Zarza V, Couraud S, Hassouni A, Prevost C, Souquet PJ, Letanche G, et al. Pulmonary diffusion test to NO and CO time course during thoracic radiotherapy for lung cancer: the CONORT prospective study protocol. Cancer Radiother. 2014;18(5–6):420–4. PubMed Epub 2014/09/11. Evolution de la double diffusion au CO et au NO au cours de la radiotherapie pulmonaire pour cancer bronchique : presentation du protocole de l’etude prospective Conort. fre.
Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(13):2181–90. PubMed Epub 2010/03/31. eng.
Curran Jr WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452–60. PubMed Pubmed Central PMCID: 3186782, Epub 2011/09/10. eng.
Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;85(2):444–50. PubMed Pubmed Central PMCID: 3448004, Epub 2012/06/12. eng.
Semrau S, Klautke G, Fietkau R. Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: a single-center analysis of 161 cases. Int J Radiat Oncol Biol Phys. 2011;79(1):96–104. PubMed Epub 2010/03/31. eng.
Castillo R, Pham N, Ansari S, Meshkov D, Castillo S, Li M, et al. Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer. Radiat Oncol. 2014;9:74. PubMed Pubmed Central PMCID: 3995607, Epub 2014/03/15. eng.
Hodge CW, Tome WA, Fain SB, Bentzen SM, Mehta MP. On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy. Med Dosim. 2010;35(4):297–303. PubMed Pubmed Central PMCID: 2975877, Epub 2009/12/01. eng.
Ireland RH, Din OS, Swinscoe JA, Woodhouse N, van Beek EJ, Wild JM, et al. Detection of radiation-induced lung injury in non-small cell lung cancer patients using hyperpolarized helium-3 magnetic resonance imaging. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2010;97(2):244–8. PubMed Epub 2010/08/21. eng.
Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, et al. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68(5):1349–58. PubMed Epub 2007/04/21. eng.
Vinogradskiy YY, Castillo R, Castillo E, Chandler A, Martel MK, Guerrero T. Use of weekly 4DCT-based ventilation maps to quantify changes in lung function for patients undergoing radiation therapy. Med Phys. 2012;39(1):289–98. PubMed Epub 2012/01/10. eng.
Hoover DA, Capaldi DP, Sheikh K, Palma DA, Rodrigues GB, Dar AR, et al. Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial. BMC Cancer. 2014;14:934. PubMed Pubmed Central PMCID: 4364501, Epub 2014/12/17. eng.
Yamamoto T, Kabus S, von Berg J, Lorenz C, Keall PJ. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79(1):279–88. PubMed Epub 2010/07/22. eng.
Shaverdian N, Veruttipong D, Wang J, Schaue D, Kupelian P, Lee P. Pretreatment immune parameters predict for overall survival and toxicity in early-stage non-small-cell lung cancer patients treated with stereotactic body radiation therapy. Clin Lung Cancer. 2015. pii: [Epub ahead of print]:S1525-7304(15)00187-4.
Selek U, Bolukbasi Y, Welsh JW, Topkan E. Intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy strategies for locally advanced Non-small-cell lung cancer. Balkan Med J. 2014;31(4):286–94. PubMed Pubmed Central PMCID: 4318398, Epub 2015/02/11. eng.
Miller KL, Shafman TD, Marks LB. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer. Semin Radiat Oncol. 2004;14(4):298–307. PubMed Epub 2004/11/24. eng.
Chance WW, Rice DC, Allen PK, Tsao AS, Fontanilla HP, Liao Z, et al. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis. Int J Radiat Oncol Biol Phys. 2015;91(1):149–56. PubMed Epub 2014/12/03. eng.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sezen, D., Bolukbasi, Y., Topkan, E., Selek, U. (2016). Selection Criteria for Definitive Treatment Approach in Thoracic Malignancies: Radiation Oncology Perspective. In: Ozyigit, G., Selek, U., Topkan, E. (eds) Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-28761-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28761-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28759-1
Online ISBN: 978-3-319-28761-4
eBook Packages: MedicineMedicine (R0)